Wilen Investment Management Has Cut Its Holding in Standex Intl Cp (SXI) by $986,160 as Share Price Declined; Abbott Laboratories (ABT) Holder Hartford Investment Management Co Trimmed Position by $309,891

February 21, 2018 - By Pete Kolinski

Wilen Investment Management Corp decreased its stake in Standex Intl Cp (SXI) by 8.63% based on its latest 2017Q3 regulatory filing with the SEC. Wilen Investment Management Corp sold 9,392 shares as the company’s stock declined 6.55% while stock markets rallied. The institutional investor held 99,464 shares of the industrial machinery and components company at the end of 2017Q3, valued at $10.49M, down from 108,856 at the end of the previous reported quarter. Wilen Investment Management Corp who had been investing in Standex Intl Cp for a number of months, seems to be less bullish one the $1.24 billion market cap company. The stock decreased 0.36% or $0.35 during the last trading session, reaching $96.9. About 857 shares traded. Standex International Corporation (NYSE:SXI) has risen 11.03% since February 21, 2017 and is uptrending. It has underperformed by 5.67% the S&P500.

Hartford Investment Management Co decreased its stake in Abbott Laboratories (ABT) by 1.43% based on its latest 2017Q3 regulatory filing with the SEC. Hartford Investment Management Co sold 5,847 shares as the company’s stock declined 3.42% while stock markets rallied. The institutional investor held 402,286 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $21.47 million, down from 408,133 at the end of the previous reported quarter. Hartford Investment Management Co who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $104.25 billion market cap company. The stock increased 0.97% or $0.575 during the last trading session, reaching $59.695. About 1.08 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 21, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Since August 30, 2017, it had 0 insider purchases, and 1 insider sale for $189,288 activity.

Among 6 analysts covering Standex Int’l Corp. (NYSE:SXI), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Standex Int’l Corp. had 8 analyst reports since August 11, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 27 by Wunderlich. The stock of Standex International Corporation (NYSE:SXI) earned “Buy” rating by FBR Capital on Monday, July 17. The company was initiated on Monday, December 12 by CJS Securities. Sidoti downgraded the stock to “Neutral” rating in Monday, December 19 report. The firm has “Sell” rating given on Tuesday, August 11 by Zacks. The firm has “Buy” rating given on Wednesday, November 29 by C.L. King.

Wilen Investment Management Corp, which manages about $240.00 million and $164.26M US Long portfolio, upped its stake in Kraton Perform (NYSE:KRA) by 21,521 shares to 98,363 shares, valued at $3.89M in 2017Q3, according to the filing.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.03, from 1.09 in 2017Q2. It fall, as 8 investors sold SXI shares while 42 reduced holdings. 17 funds opened positions while 36 raised stakes. 10.01 million shares or 0.78% less from 10.09 million shares in 2017Q2 were reported. Thrivent Fincl For Lutherans owns 7,800 shares or 0% of their US portfolio. Bessemer Group holds 0% of its portfolio in Standex International Corporation (NYSE:SXI) for 227 shares. Mason Street Advisors Limited Com holds 3,235 shares. Prudential reported 22,526 shares. Keybank Natl Association Oh reported 6,000 shares. Moreover, Fmr Ltd Liability Corporation has 0.01% invested in Standex International Corporation (NYSE:SXI). Bnp Paribas Arbitrage Sa holds 0% or 6,773 shares in its portfolio. Victory Capital Mgmt Inc reported 0.06% in Standex International Corporation (NYSE:SXI). Comerica Retail Bank accumulated 0.04% or 53,060 shares. State Teachers Retirement reported 45,543 shares or 0.01% of all its holdings. Metropolitan Life Ins New York reported 8,867 shares or 0.01% of all its holdings. Dimensional Fund Advsrs Limited Partnership, a Texas-based fund reported 585,270 shares. Texas Permanent School Fund holds 0.01% or 9,326 shares. Johnson Inv Counsel Inc invested in 0.04% or 13,814 shares. 4,320 are owned by Ubs Asset Management Americas.

Analysts await Standex International Corporation (NYSE:SXI) to report earnings on May, 1. They expect $1.17 earnings per share, up 19.39% or $0.19 from last year’s $0.98 per share. SXI’s profit will be $15.01 million for 20.71 P/E if the $1.17 EPS becomes a reality. After $1.12 actual earnings per share reported by Standex International Corporation for the previous quarter, Wall Street now forecasts 4.46% EPS growth.

Hartford Investment Management Co, which manages about $5.30B US Long portfolio, upped its stake in Spectrum Brands Holdings (NYSE:SPB) by 7,642 shares to 49,946 shares, valued at $5.29M in 2017Q3, according to the filing. It also increased its holding in Cboe Global Markets Inc (NASDAQ:CBOE) by 2,830 shares in the quarter, for a total of 24,201 shares, and has risen its stake in Henry Schein Inc (NASDAQ:HSIC).

Since September 22, 2017, it had 0 insider purchases, and 7 sales for $31.71 million activity. 227,412 shares were sold by Fussell Stephen R, worth $14.27 million on Tuesday, January 30. $1.73 million worth of Abbott Laboratories (NYSE:ABT) was sold by Blaser Brian J on Wednesday, January 31. Contreras Jaime also sold $2.74M worth of Abbott Laboratories (NYSE:ABT) shares. Ford Robert B had sold 42,665 shares worth $2.69 million on Tuesday, January 30.

Investors sentiment decreased to 0.87 in Q3 2017. Its down 0.01, from 0.88 in 2017Q2. It is negative, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Ironwood Limited Co stated it has 0.01% of its portfolio in Abbott Laboratories (NYSE:ABT). 17,076 are held by Front Barnett Associate Ltd Liability. Jefferies Gru Ltd Liability Company reported 19,762 shares. Alpine Woods Cap Investors Ltd Liability holds 0.03% or 12,633 shares in its portfolio. Gillespie Robinson & Grimm holds 0.06% of its portfolio in Abbott Laboratories (NYSE:ABT) for 8,624 shares. Renaissance Inv Gru Lc holds 7,156 shares or 0.16% of its portfolio. 31,800 were accumulated by Summit Securities Grp Lc. Ray Gerald L And Associate holds 29,897 shares. Oppenheimer holds 126,600 shares or 0.18% of its portfolio. Jolley Asset Mgmt Lc has invested 1.17% of its portfolio in Abbott Laboratories (NYSE:ABT). Putnam Investments Limited Liability Corp owns 31,673 shares. Pioneer Trust Bank & Trust N A Or invested in 1.96% or 70,670 shares. Cooke Bieler LP stated it has 1.79 million shares. Papp L Roy & Assoc invested in 9,216 shares. Qci Asset Management Ny holds 1.48% or 248,720 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, July 23. Stifel Nicolaus has “Buy” rating and $58 target. Wells Fargo maintained Abbott Laboratories (NYSE:ABT) on Thursday, January 25 with “Outperform” rating. The firm earned “Buy” rating on Thursday, September 28 by Wells Fargo. The stock of Abbott Laboratories (NYSE:ABT) earned “Market Perform” rating by BMO Capital Markets on Thursday, October 19. The firm has “Buy” rating given on Wednesday, January 24 by BMO Capital Markets. The firm has “Buy” rating by Jefferies given on Thursday, June 29. Gabelli maintained Abbott Laboratories (NYSE:ABT) on Friday, July 21 with “Buy” rating. The stock of Abbott Laboratories (NYSE:ABT) earned “Neutral” rating by Citigroup on Tuesday, January 30. The company was maintained on Thursday, August 31 by BMO Capital Markets. RBC Capital Markets maintained the shares of ABT in report on Friday, September 1 with “Buy” rating.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>